AMRUTANJAN Overzicht aandelen
Amrutanjan Health Care Limited produceert, levert en verkoopt ayurvedische pijnbalsems en dameshygiëneproducten. Meer informatie
| Sneeuwvlok Score | |
|---|---|
| Waardering | 0/6 |
| Toekomstige groei | 0/6 |
| Prestaties in het verleden | 4/6 |
| Financiële gezondheid | 6/6 |
| Dividenden | 4/6 |
Amrutanjan Health Care Limited Concurrenten
Prijsgeschiedenis en prestaties
| Historische aandelenkoersen | |
|---|---|
| Huidige aandelenkoers | ₹712.45 |
| 52 Week Hoogtepunt | ₹862.60 |
| 52 Week Laag | ₹570.00 |
| Bèta | 0.74 |
| 11 maand verandering | -1.30% |
| 3 maanden verandering | -14.39% |
| 1 Jaar Verandering | 16.58% |
| 33 jaar verandering | -19.87% |
| 5 jaar verandering | 53.35% |
| Verandering sinds IPO | 1,441.77% |
Recent nieuws en updates
Amrutanjan Health Care (NSE:AMRUTANJAN) Is Paying Out A Dividend Of ₹1.00
Nov 19
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 31Recent updates
Amrutanjan Health Care (NSE:AMRUTANJAN) Is Paying Out A Dividend Of ₹1.00
Nov 19Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 31Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 17We Think You Should Be Aware Of Some Concerning Factors In Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings
May 31Pinning Down Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) P/E Is Difficult Right Now
May 03Amrutanjan Health Care (NSE:AMRUTANJAN) Has Affirmed Its Dividend Of ₹1.00
Feb 12Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹2.60
Sep 02Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 19Amrutanjan Health Care (NSE:AMRUTANJAN) Is Due To Pay A Dividend Of ₹2.60
Aug 05Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹1.00
Feb 17Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹1.00
Nov 08Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹2.60
Aug 18Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Vies For A Place In Your Dividend Portfolio: Here's Why
Apr 30Should You Be Adding Amrutanjan Health Care (NSE:AMRUTANJAN) To Your Watchlist Today?
Apr 08Introducing Amrutanjan Health Care (NSE:AMRUTANJAN), The Stock That Zoomed 162% In The Last Five Years
Mar 11Trade Alert: The Non-Executive Independent Director Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN), Govindan Raghavan, Has Just Spent ₹72k Buying A Few More Shares
Feb 24Is It Smart To Buy Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Before It Goes Ex-Dividend?
Feb 14Is Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Latest Stock Performance A Reflection Of Its Financial Health?
Feb 12Is Amrutanjan Health Care Limited (NSE:AMRUTANJAN) A Smart Choice For Dividend Investors?
Jan 30
Is There More To The Story Than Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings Growth?
Jan 17Here's Why I Think Amrutanjan Health Care (NSE:AMRUTANJAN) Is An Interesting Stock
Jan 04What Type Of Shareholders Make Up Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Share Registry?
Dec 22How Much is Amrutanjan Health Care's (NSE:AMRUTANJAN) CEO Getting Paid?
Dec 09If You Had Bought Amrutanjan Health Care (NSE:AMRUTANJAN) Stock Five Years Ago, You Could Pocket A 106% Gain Today
Nov 26Here's What We Like About Amrutanjan Health Care's (NSE:AMRUTANJAN) Upcoming Dividend
Nov 14Why Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Should Be In Your Dividend Portfolio
Oct 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Amrutanjan Health Care Limited's NSE:AMRUTANJAN) Stock?
Oct 10I Ran A Stock Scan For Earnings Growth And Amrutanjan Health Care (NSE:AMRUTANJAN) Passed With Ease
Sep 22What Percentage Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares Do Insiders Own?
Sep 01With Amrutanjan Health Care Limited (NSE:AMRUTANJAN) It Looks Like You'll Get What You Pay For
Aug 11Have Insiders Been Selling Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares?
Jul 29Rendement voor aandeelhouders
| AMRUTANJAN | IN Pharmaceuticals | IN Markt | |
|---|---|---|---|
| 7D | -1.6% | 2.3% | 2.4% |
| 1Y | 16.6% | 43.8% | 29.5% |
Rendement versus industrie: AMRUTANJAN presteerde slechter dan de Indian Pharmaceuticals -sector, die het afgelopen jaar een rendement van 43.8 % opleverde.
Rendement versus markt: AMRUTANJAN presteerde slechter dan Indian Market, dat het afgelopen jaar een rendement van 29.5 % opleverde.
Prijsvolatiliteit
| AMRUTANJAN volatility | |
|---|---|
| AMRUTANJAN Average Weekly Movement | 4.8% |
| Pharmaceuticals Industry Average Movement | 6.2% |
| Market Average Movement | 6.1% |
| 10% most volatile stocks in IN Market | 9.1% |
| 10% least volatile stocks in IN Market | 4.0% |
Stabiele aandelenkoers: AMRUTANJAN heeft de afgelopen 3 maanden geen significante prijsvolatiliteit gekend.
Volatiliteit in de loop van de tijd: De wekelijkse volatiliteit ( 5% ) van AMRUTANJAN is het afgelopen jaar stabiel geweest.
Over het bedrijf
| Opgericht | Werknemers | CEO | Website |
|---|---|---|---|
| 1893 | 634 | Sambhu Sivalenka | www.amrutanjan.com |
Amrutanjan Health Care Limited produceert, levert en verkoopt ayurvedische pijnbalsems en hygiëneproducten voor vrouwen. Het bedrijf is actief in de segmenten OTC-producten, dranken en overige. Het bedrijf levert pijnbestrijdingsproducten, waaronder pijnbalsems en roll-ons; en rugpijn roll-ons, stick-on patch, body pain gels en joint muscle sprays.
Amrutanjan Health Care Limited Samenvatting
| AMRUTANJAN fundamentele statistieken | |
|---|---|
| Marktkapitalisatie | ₹20.64b |
| Inkomsten(TTM) | ₹475.20m |
| Inkomsten(TTM) | ₹4.38b |
43.4x
Koers/Winstverhouding4.7x
P/S-verhoudingIs AMRUTANJAN overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
| AMRUTANJAN resultatenrekening (TTM) | |
|---|---|
| Inkomsten | ₹4.38b |
| Kosten van inkomsten | ₹2.24b |
| Brutowinst | ₹2.14b |
| Overige uitgaven | ₹1.66b |
| Inkomsten | ₹475.20m |
Laatst gerapporteerde inkomsten
Sep 30, 2024
Volgende inkomensdatum
n.v.t.
| Winst per aandeel (EPS) | 16.44 |
| Brutomarge | 48.86% |
| Nettowinstmarge | 10.85% |
| Schuld/Eigen Vermogen Verhouding | 0% |
Hoe presteerde AMRUTANJAN op de lange termijn?
Bekijk historische prestaties en vergelijkingDividenden
0.6%
Huidig dividendrendement28%
UitbetalingsratioBetaalt AMRUTANJAN een betrouwbaar dividend?
Zie AMRUTANJAN dividendgeschiedenis en benchmarks| Amrutanjan Health Care dividenddata | |
|---|---|
| Ex Dividend Datum | Nov 22 2024 |
| Betaaldatum dividend | Dec 12 2024 |
| Dagen tot Ex-dividend | 5 days |
| Dagen tot dividendbetaaldatum | 15 days |
Betaalt AMRUTANJAN een betrouwbaar dividend?
Zie AMRUTANJAN dividendgeschiedenis en benchmarks